Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livius Penter

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Blood Cancer Discovery|April 28, 2025
Putting AML Differentiation States on the BoneMarrowMapJonas Berger, Livius Penter
British Journal of Haematology|April 23, 2026
Not all Tregs in MDS are created equalMischa Selig, Livius Penter
The Journal of Clinical Investigation|January 28, 2020
Personal tumor antigens in blood malignancies: genomics-directed identification and targetingLivius Penter, Catherine J Wu
Blood|September 12, 2024
Therapy response in AML: a tale of two T cellsLivius Penter, Catherine J Wu
Blood|September 15, 2022
AML relapse after a TIGIT raceLivius Penter, Catherine J Wu
Frontiers in Immunology|January 20, 2022
Natural Barcodes for Longitudinal Single Cell Tracking of Leukemic and Immune Cell DynamicsLivius Penter, Satyen H Gohil, Catherine J Wu
Clinical Hematology International|June 17, 2024
Single-cell genomics-based immune and disease monitoring in blood malignanciesAnja C Rathgeber, Leif S Ludwig, Livius Penter
Cancer Immunology Research|August 4, 2017
Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone MarrowLeo Hansmann, Arnold Han, Livius Penter, et al.
European Journal of Immunology|March 15, 2018
FACS single cell index sorting is highly reliable and determines immune phenotypes of clonally expanded T cellsLivius Penter, Kerstin Dietze, Lars Bullinger, et al.
Targeted Oncology|January 7, 2015
A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastomaLivius Penter, Bert Maier, Ute Frede, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Blood Cancer Discovery|April 28, 2025
Putting AML Differentiation States on the BoneMarrowMapJonas Berger, Livius Penter
British Journal of Haematology|April 23, 2026
Not all Tregs in MDS are created equalMischa Selig, Livius Penter
The Journal of Clinical Investigation|January 28, 2020
Personal tumor antigens in blood malignancies: genomics-directed identification and targetingLivius Penter, Catherine J Wu
Blood|September 12, 2024
Therapy response in AML: a tale of two T cellsLivius Penter, Catherine J Wu
Blood|September 15, 2022
AML relapse after a TIGIT raceLivius Penter, Catherine J Wu
Frontiers in Immunology|January 20, 2022
Natural Barcodes for Longitudinal Single Cell Tracking of Leukemic and Immune Cell DynamicsLivius Penter, Satyen H Gohil, Catherine J Wu
Clinical Hematology International|June 17, 2024
Single-cell genomics-based immune and disease monitoring in blood malignanciesAnja C Rathgeber, Leif S Ludwig, Livius Penter
Cancer Immunology Research|August 4, 2017
Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone MarrowLeo Hansmann, Arnold Han, Livius Penter, et al.
European Journal of Immunology|March 15, 2018
FACS single cell index sorting is highly reliable and determines immune phenotypes of clonally expanded T cellsLivius Penter, Kerstin Dietze, Lars Bullinger, et al.
Targeted Oncology|January 7, 2015
A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastomaLivius Penter, Bert Maier, Ute Frede, et al.
Pageof 5